Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2013 / Cilt: 23 - Sayı: 1

Filatelide Tıp, Pullarla Hematoloji ve Onkoloji

Medicine in philately hematology and oncology with stamps

Pages
66–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper provides an overview to the main historical aspects of hematology and leukemiathrough philately.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The importance given to blood and the understanding of cancer are the two oldest features of medical history.
📊
Key Findings & Data:These two conceptsare combined in our current description as hematologic oncology.
💡
Conclusion & Impact:This paper provides an overview to the main historical aspects of hematology and leukemiathrough philately.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The importance given to blood and the understanding of cancer are the two oldest features of medical history. These two conceptsare combined in our current description as hematologic oncology. Today the three main types of blood cancer are known as lymphoma, leukemia and multiple myeloma. Each varies slightly in terms of treatment, prognosis and symptoms. Beginning from the disco very of blood circulation and blood grouping, with many new techniques in diagnosis and treatment modalities; the approach to hematology and oncology evolved a lot. This paper provides an overview to the main historical aspects of hematology and leukemiathrough philately.

Özet

Kana verilen önem ve kanserin tanınması tıp tarihinin en eski iki olgusudur. Bu iki kavram günümüzde hematolojik onkoloji tanımıyla biraraya getirilmiştir. Bugün bilinen üç kan kanseri türü lenfoma, lösemi ve multiple myeloma olarak sınıflandırılmaktadır. Her biri tedavi prognoz ve semptomlar açısından farklılıklar göstermektedir. Hematoloji ve onkoloijiye yaklaşımımız gerek kan dolaşımı ve kan gruplarının keşfi gerekse tanı ve tedaviye yönelik birçok yeni tekniğin gelişmesiyle birlikte köklü bir evrime uğramıştır. Bu çalışma hematoloji ve löseminin temel tarihsel sürecine filateli aracılığı ile genel bir bakış sunmayı hedeşemektedir.

🔖

Cite This Article

ATAMAN, A. D., VATANOGLU-LUTZ, E. E. (2013). Filatelide Tıp, Pullarla Hematoloji ve Onkoloji. Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 23 - Sayı: 1, 66–72. https://ajindex.com/articles/322895

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Zuskin E, Lipozenci J, Pucarin-Cvetkovi J, et al. Anci- ent medicine - A review. Acta Dermatovenerol Croat 16: 149-157, 2008
  2. Kanellou V. Ancient Greek medicine as the foundation of contemporary medicine. Tech Coloproctol 8: 3-4, 2004
  3. Karamanou M, Androutsos G, Diamantis A. Cancer and Roman medicine. J BUON 14: 537-540, 2009
  4. Day MH. Louis Leakey. J Anat 114: 463-464, 1973
  5. Parsa N. Environmental factors inducing human can- cers. Iran J Public Health 41: 1-9, 2012. 6. de Micheli A, Izaguirre-Avila R. Evolution of knowledge on blood and its movement. 1st Part. Integration of cir- culatory doctrine, Iatrophysics of blood. Rev Invest Clin 56: 783-792, 2004
  6. Azzali G. Historical notes on the lymphatic vascular system. Acta Biomed Ateneo Parmense 61: 113-125, 1990
  7. Schwarz HP, Dorner F. Karl Landsteiner and his major contributions to haematology. Br J Haematol 121: 556-565, 2003
  8. Brown TM, Fee E. Rudolf Carl Virchow: Medical scien- tist, social reformer, role model. Am J Public Health 96: 2104-2105, 2006
  9. Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH. Virchow's contribution to the understanding of throm- bosis and cellular biology. Clin Med Res 8: 168-172, 2010
  10. Bignold LP, Coghlan BL, Jersmann HP. Virchow's "cellular pathology" 150 years later. Semin Diagn Pat- hol 25: 140-146, 2008
  11. Patel MI, Ma Y, Mitchell BS, Rhoads KF. Understan- ding disparities in leukemia: a national study. Cancer Causes Control 23: 1831-1837, 2012
  12. Neumann-Redlin von Meding E. Neumann's dentin sheaths and Tomes' dentin fibers. On the 150th anni- versary of the birth of Königsberg pathologist Ernst Christian Neumann. Dtsch Zahnarztl Z 39: 65-69, 1984
  13. Miller DR. A tribute to Sidney Farber- the father of mo- dern chemotherapy. Br J Haematol 134: 20-26, 2006
  14. Collins DJ. Albertus, Magnus or Magus? Magic, Nat- ural Philosophy, and Religious Reform in the Late Middle Ages. Renaissance Quarterly 63: 1-44, 2010
  15. Zhou J. Arsenic trioxide: an ancient drug revived. Chin Med J (Engl) 125: 3556-3560, 2012
  16. Doss M. Shifting the paradigm in radiation safety. Dose Response 10: 562-583, 2012
  17. Thariat J, Hannoun-Levi JM, Sun Myint A, Vuong T, Gérard JP. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol 10: 52- 60, 2012
  18. Calabrese EJ. Muller's Nobel lecture on dose-respon- se for ionizing radiation: Ideology or science? Arch Toxicol 85: 1495-1498, 2011
  19. Ghanei M, Vosoghi AA. An epidemiologic s